Summary
The effects of the low molecular weight serine proteinase inhibitor FOY (gabexate mesilate) upon insulin action was studied in three different experimental systems. Placenta membranes containing insulin receptors preincubated with FOY (10 μM) showed a reduction of insulin-stimulated tyrosine kinase activity (p<0.01). However, FOY (0.1–100 μM) did not affect the insulin-stimulated tyrosine kinase activity in a preparation of solubilized and partially purified insulin receptors from placental membranes. Isolated adipocytes were used to study the effect of FOY on intact cells. FOY neither altered the insulin induced inhibition of the catecholamine-stimulated lipolysis nor (at the low concentration of 0.1 mM) the stimulation of glucose transport by the hormone. High concentrations (0.5 mM) of FOY decreased the effect of insulin on the hexose transport.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Denton, R.M., Brownsey, R.W. and Belsham, G.J., A partial view of the mechanism of insulin action, Diabetologia, 1981; 21: 347–362.
Gammeltoft, S., Insulin receptors: binding kinetics and structure-function relationship of insulin, Physiol. Rev., 1984; 64: 1321–1378.
Seals, J.R. and Czech, M.P., Evidence that insulin activates an intrinsic plasma membrane protease in generating a secondary chemical mediator. J. Biol. Chem., 1980; 255: 6529–6531.
Göke, B., Printz, H., Koop, J., Rausch, U., Richter, G., Arnold, R. and Adler, G., Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate), Pancreas, 1986; 1: 509–515.
Keim, V. and Göke, B., Pancreatic secretion in the rat influenced by the low molecular weight proteinase inhibitor gabexate mesilate, Eur. J. Clin. Invest., 1986; 16: 511–519.
Goebell, H., Schmitz-Moormann, P., Pfannkuch, U. and Wiechmann, A., Hypertrophy of the exocrine pancreas: Induction by oral application of the synthetic trypsin inhibitor FOY 305 in rats, Digestion, 1983; 28: 31 (Abstr.).
Williams, J. A. and Goldfine, I.D., The insulin-pancreatic acinar axis, Diabetes, 1985; 34: 980–986.
Seals, J. R. and Czech, M. P., Production by plasma membranes of a chemical medicator of insulin action, Fed. Proc., 1982; 41: 2730–2735.
Machicao, F., Urumow, T. and Wieland, O. H., Phosphorylation-dephosphorylation of purified insulin receptor from human placenta. Effect of insulin, FEBS Lett., 1982; 149: 96–100.
Joost, H.G., Steinfelder, H.J. and Schmitz-Salue, C., Tyrosine kinase activity of insulin receptors from human placenta, Biochem. J., 1986; 233: 677–681.
Rodbell, M., Metabolism of isolated fat cells I. Effects of hormones of glucose metabolism and lipolysis. J. Biol. Chem., 1964; 239: 375–380.
Joost, H.G. and Steinfelder, H.J., Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte, Mol. Pharmac., 1982; 22: 614–618.
Nash, T., The colorimetric estimation of formaldehyde by means of Hantzsch reaction, Biochem. J., 1953; 55: 416–421.
Whitesell, R. R. and Gliemann, J., Kinetic parameters of transport of 3-0-methylglucose and glucose in adipocytes, J. Biol. Chem., 1979; 254: 5279–5283.
Weber, T.M., Joost, H.G., Simpson, I.A. and Cushman, S.W., Methods for assessment of glucose transport activity and the number of glucose transporters in isolated rat adipose cells and membrane fractions. In: C.R. Kahn and L.C. Harrison (Eds.), The Insulin Receptor, A.R. Liss Inc., New York, 1986, in press.
Göke, B., Göke, R. and Lankisch, P.G., Influence of a low molecular weight serine proteinase inhibitor (camostate) on lipolysis of isolated adipocytes, Res. Exp. Med., 1985; 185: 503–507.
Larner, J., Insulin and glycogen synthase, 1972; 21: 428–438.
Larner, J., Galasko, G., Cheng, K., Depaoli-Roach, A.A., Huang, L., Daggy, P. and Kellog, J., Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation, Science, 1979; 206: 1408–1410.
Seals, J.R. and Jarett, L., Activation of pyruvate dehydrogenase by direct addition of insulin to an isolated plasma membrane/mitochondria mixture: Evidence for generation of insulin's second messenger in a subcellular system, Proc. Natl. Acad. Sci., 1980; 77: 77–81.
Jarett, L., Kiechle, F.L. and Parker, J.C., Chemical mediator or mediators of insulin action: response to insulin and mode of action, Fed. Proc., 1982; 41: 2736–2741.
Larner, J., Cheng, K., Schwartz, C., Dubler, R., Creacy, S., Kikuchi, K., Tamura, S., Galasko, G., Pullin, C. and Katz, M., Chemical mechanism of insulin action via a proteolytic formation of mediator peptides, Mol. Cell. Biochem., 1982; 40: 155–161.
Muchmore, D.B., Raess, B.U., Bergstrom, R.W. and Dehaen, C., On the mechanisms of inhibition of insulin action by small-molecular-weight trypsin inhibitors, Diabetes, 1982; 31: 976–984.
Söling, H.D. and Unger, K.O., The role of insulin in the regulation of α-amylase synthesis in the rat pancreas, Europ. J. Clin. Invest., 1972; 2: 199–212.
Mössner, J., Logsdon, C.D., Williams, J.A. and Goldfine, I.D., Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells, Diabetes, 1985; 34: 891–897.
Geratz, J.D. and Hurt, J.P., Regulation of pancreatic enzyme levels by trypsin inhibitors, Am. J. Physiol., 1970; 219: 705–711.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Göke, R., Göke, B., Steinfelder, HJ. et al. Influence of a small molecular weight proteinase inhibitor, gabexate mesilate (FOY), on insulin receptor function in vitro. Int J Pancreatol 3, 135–142 (1988). https://doi.org/10.1007/BF02798924
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02798924